SCHEMBL21591671

SCHEMBL21591671

Cc1ncc(Br)cc1CC=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
AOX1 Q06278 1/20 0.34
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HTT P42858 1/20 0.31
AURKA O14965 1/20 0.30
DAPK3 O43293 1/20 0.30
JAK2 O60674 1/20 0.30
PRKD3 O94806 1/20 0.30
MAP4K4 O95819 1/20 0.30
PAK4 O96013 1/20 0.30
ABL1 P00519 1/20 0.30
NTRK1 P04629 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17427757 0.80 NOS3 (0.39) ALDH1A1KDM4EKMT2AHSD17B10SMN1; SMN2
SCHEMBL5592987 0.79 NOS3 (0.36) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL2144297 0.78 ALDH1A1 (0.33) ALDH1A1KMT2AHTTAURKADAPK3
SCHEMBL15922497 0.78 ALDH1A1 (0.33) ALDH1A1KMT2AHTTAURKADAPK3
SCHEMBL24248614 0.77 MEN1 (0.32) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL14764186 0.77 CNR2 (0.34) ALDH1A1KMT2AMEN1HSD17B10SMN1; SMN2
Methyl Alcohol SCHEMBL10757708 0.77 NOS3 (0.37) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL15699752 0.76 SMN1; SMN2 (0.36) ALDH1A1KDM4EKMT2AHPGDHSD17B10
SCHEMBL21591653 0.75 ALDH1A1 (0.32) ALDH1A1
SCHEMBL22771018 0.75 SMN1; SMN2 (0.35) ALDH1A1KDM4EKMT2AHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3807270-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2021-04-21 EP disclosed
EP-3710435-A1 OX1 ANTAGONISTS Heptares Therapeutics Limited (GB) 2020-09-23 EP disclosed
WO-2019238616-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2019-12-19 WO disclosed